Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

Condition:   Systemic Lupus Erythematosus (SLE) Intervention:   Biological: BRL-301 Sponsors:   Bioray Laboratories;   First Affiliated Hospital of Zhejiang University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Lupus | Research